386例心房纤颤的临床分析

目的总结386例房颤患者发病,以胺碘酮控制心率和华法令抗凝临床治疗效果和经验。方法386例房颤患者根据临床表现,使用胺碘酮控制心率和华法令抗凝治疗,随访时间为1年,总结临床治疗情况。结果360例多数患者经治疗症状缓解,临床治愈,治愈率为93.3%(360/386);26例因心衰死亡,死亡率为6.7%(26/386)。结论房颤患者通过胺碘酮控制心率和华法令抗凝治疗,临床治疗效果良好。

Objective To evaluate the clinical efficacy and experience on patients with fibrillation by amiodarone and warfarin. Methods 386 pa tients with atrial fibrillation were treated with amiodarone and warfarin.The duration of observation was up to one year.The clinic status was sum marized. Results 360 patients with atrial fibrillation were cured 93.3%（360/386）;26 patients with atrial fibrillation were death ,The death date was 6.7%（26/386）. Conclusion Oral amiodarone ＋ warfarin is effective and safe method for nonvalvular atrial fibrillation.